Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ANTIBODY SPECIFICALLY RECOGNIZING 4-1BB, PREPARATION METHOD THEREFOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/143534
Kind Code:
A1
Abstract:
Disclosed are an antibody specifically recognizing 4-1BB, a preparation method therefor and use thereof. The antibody comprises a heavy chain variable region and a light chain variable region. The heavy chain variable region comprises HCDR1, HCDR2, and HCDR3, and the light chain variable region comprises LCDR1, LCDR2, and LCDR3. The sequence information of these regions is detailed in a sequence table. The antibody prepared in the present invention has better performance in affinity, better effect in inhibiting tumor growth in vivo, and smaller toxic and side effects.

Inventors:
LI SHUANGQI (CN)
LANG GUOJUN (CN)
TAN YONGCONG (CN)
ZHOU YUNHUA (CN)
YAN XINTIAN (CN)
FU ZIBO (CN)
Application Number:
PCT/CN2023/073605
Publication Date:
August 03, 2023
Filing Date:
January 28, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SANYOU BIOPHARMACEUTICALS CO LTD (CN)
International Classes:
C07K16/28; A61K39/00; A61K39/395; A61P35/00; C07K19/00
Domestic Patent References:
WO2022002063A12022-01-06
Other References:
DATABASE Nucleotide 23 July 2019 (2019-07-23), ANONYMOUS : "Homo sapiens clone ISD068GL P2E3 Kappa immunoglobulin kappa chain variable region mRNA, partial cds", XP093080979, retrieved from NCBI Database accession no. MN037684
DATABASE Nucleotide 26 July 2016 (2016-07-26), ANONYMOUS : "Homo sapiens clone BF3N1-K3-C4/L6-2-P immunoglobulin kappa light chain variable region gene, partial cds.", XP093080984, retrieved from NCBI Database accession no. AF386270
DATABASE Nucleotide 23 July 2019 (2019-07-23), ANONYMOUS : "Homo sapiens clone ISD068GL P2E3 Heavy immunoglobulin heavy chain variable region mRNA, partial cds.", XP093080987, retrieved from NCBI Database accession no. MN037683
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF: